Opinion · 31 Jan 2025
EditorialPublished Dec 2021
Angiotensin
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
is a peptide endocrine chemical and a significant piece of the renin-angiotensin-aldosterone framework, a between related endocrine framework significant in volume and pulse control. Angiotensinogen, an alpha-globulin, and the peptide prohormone is orchestrated principally by the liver and circles in plasma. At the point when pulse drops, or when thoughtful signs arrive at the kidney, renin, a peptide delivered basically by the renal juxtaglomerular cells, is delivered and enzymatically separates off two amino acids shaping angiotensin I (ATI), a decapeptide. ATI is additionally severed into an octapeptide, angiotensin II (ATII) by the activity of angiotensin-changing over catalyst (ACE), basically in the aspiratory endothelium, however this compound is available in the endothelium of different organs including the heart. ATII is an intense vasopressor, following up on vascular endothelial receptors. The two sorts of ATII receptors present in the heart and vasculature smooth muscle that are answerable for signal transduction in intervening the vasoconstrictive activity of ATII are the AT1 and AT2 receptors. Their flagging prompts calciumsubordinate phosphorylation of myosin, which prompts compression of the vascular smooth muscle. This blood vessel smooth muscle withdrawal is answerable for raising blood pressure… Additionally, ATII communicates with AT receptors at different destinations in the nephron to animate sodium reabsorption. ATII likewise follows up on the zona glomerulosa of the adrenal cortex to animate the arrival of aldosterone, a steroid chemical that follows up on the kidney to advance sodium and water maintenance. Angiotensinchanging over chemical inhibitors (ACEI) may expand the impact of IV angiotensin II, and the utilization of angiotensin receptor blockers (ARB) may lessen the impact of IV angiotensin II. The component for the connection with ACEIs isn’t indicated. The connection with ARBs is by pharmacodynamic opposition of the medication at the receptor site.
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 28 Feb 2024
The Renin-angiotensin System and its Role in Cardiovascular-kidney-metabolic syndrome
Commentary · 5 Dec 2022
Comprehensive study on renin-angiotensin system
Opinion · 10 Jan 2022
Prescriptions that Slow Down Urinary Discharge by Restraining the Renin-Angiotensin Framework
Editorial · 23 Dec 2021
Angiotensin Type-2 Receptors in Renal Proximal Tubule
More from this journal
The newest in Journal of Nephrology & Renal Diseases.
Opinion · 4 Dec 2023
Navigating the Path to Diagnosis: Understanding Kidney Diseases
Opinion · 4 Dec 2023
Unveiling Diuretics: A Comprehensive Exploration of a Vital Drug Class
Perspective · 4 Dec 2023
The Silent and Progressive Threat of Hypertensive Nephropathy: Risk Factors and Treatment Options
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology & Renal Diseases
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Kalyan Kumar”

